Birchview Capital, LP - TRANSLATE BIO INC ownership

TRANSLATE BIO INC's ticker is TBIO and the CUSIP is 89374L104. A total of 151 filers reported holding TRANSLATE BIO INC in Q4 2020. The put-call ratio across all filers is 7.16 and the average weighting 0.2%.

Quarter-by-quarter ownership
Birchview Capital, LP ownership history of TRANSLATE BIO INC
ValueSharesWeighting
Q2 2021$826,000
+66.9%
30,0000.0%0.49%
+68.0%
Q1 2021$495,000
-10.5%
30,0000.0%0.29%
-7.8%
Q4 2020$553,000
-32.2%
30,000
-50.0%
0.32%
+16.8%
Q3 2020$816,000
+51.7%
60,000
+100.0%
0.27%
-16.0%
Q2 2020$538,000
+79.9%
30,0000.0%0.32%
+22.6%
Q1 2020$299,00030,0000.26%
Other shareholders
TRANSLATE BIO INC shareholders Q4 2020
NameSharesValueWeighting ↓
Atlas Venture Advisors, Inc. 2,656,517$48,960,00010.98%
Copernicus Capital Management, LLC 12,091$223,0003.48%
FRAZIER MANAGEMENT LLC 2,182,789$40,229,0003.10%
Baupost Group 18,044,239$326,236,0003.01%
DAFNA Capital Management LLC 225,393$4,154,0001.24%
RTW INVESTMENTS, LP 2,978,427$54,892,0000.92%
MARATHON CAPITAL MANAGEMENT 143,275$2,640,0000.78%
Bain Capital Public Equity Management II, LLC 627,387$11,563,0000.59%
Artal Group S.A. 1,200,000$22,116,0000.48%
Birchview Capital, LP 30,000$553,0000.32%
View complete list of TRANSLATE BIO INC shareholders